GSRS(Gastrointestinal Symptom Rating Scale)-Based Investigation about Gastrointestinal Symptoms and Histories in Patients with Asthmatic Symptoms

GSRS에 근거한 천식증상환자 중의 소화기증상 및 과거력에 대한 조사

  • 이재성 (경희대학교 한의과대학 폐계내과학교실) ;
  • 정승연 (경희대학교 한의과대학 폐계내과학교실) ;
  • 이건영 (경희대학교 한의과대학 폐계내과학교실) ;
  • 최준용 (경희대학교 한의과대학 폐계내과학교실) ;
  • 정희재 (경희대학교 한의과대학 폐계내과학교실) ;
  • 이형구 (경희대학교 한의과대학 폐계내과학교실) ;
  • 정승기 (경희대학교 한의과대학 폐계내과학교실)
  • Published : 2004.03.01

Abstract

Backgrounds & Methods : Asthma is considered to be chronic inflammatory disease characterized by airway hyperresponsiveness and pulmonary eosinophilia. Recently, there has been many researches about asthma. IBS(Irritable Bowel Syndrome), PUD(peptic Ulcer disease) and GERD(gastroesophageal reflux disease) are the most common diseases of the gastrointestinal tract. Recent studies suggest that IBS, PUD and GERD are associated with bronchial hyper-responsiveness and bronchial asthma might be more prevalent in IBS and GERD patients than in control subjects. In addition, there are many comments about the interrelationship between the gastrointestinal problem and asthma in the oriental medical books. Actually, many oriental medical doctors don$^{\circ}$Øt consider the gastrointestinal condition when they deal with the asthmatic patients these days. So, we assessed the prevalence of gastrointestinal symptoms and histories in a cohort of patients with asthmatic symptoms. We evaluated 128 outpatients with asthmatic symptoms(60 males and 68 females, aged 13-75). All subjects enrolled completed the GSRS(Gastrointestinal Symptom Rating Scale). GSRS is an interview based rating scale consisting of 15 items for assessment of gastrointestinal symptoms in IBS and PUD developed by Jan Svedlund. Results : The limit of total score of GSRS in asthmatic patients is zero to 30. The number of patients with no GI symptoms is 66(51.5%). The number of patients with GSRS>5 is 62(48.4%), GSRS>10 is 24(18.8%), GSRS>15 is 8(6.25%). The number of patients with history of gastritis is 54(42.2%), gastric ulcer is 13(10.2%), gastroptosis is 8(6.25%), IBS is 6(4.68%), others is 6(4.68%). Conclusions : This study suggests that patients with bronchial asthma have an significant prevalence of gastrointestinal symptoms. Additional studies are needed to find the mechanism of the association between gastrointestinal symptoms and asthma.

Keywords

References

  1. 임상호흡기학 한용철
  2. N Y State J Med. v.66 no.23 Esophageal reflux as trigger in asthma Overholt, R.H.;Ashraf, M.M.
  3. 東醫寶鑑 許俊
  4. Am J Respir Crit Care Med. v.164 Is Asthma Really Due to a Polarized T Cell Response Toward a Helper T Cell Type 2 Phenotype? Sundeep S;Salvi K;Suresh Babu;Stephen T. Holgte
  5. 천식과 알레르기 질환 대한 천식 및 알레르기학회
  6. 세포 분자면역학 Abul K. Abbas;Andrew H. Lichtman;Jordan S. Pober
  7. 東醫肺系內科學 전국한의과대학 폐계내과학교실(편저)
  8. 경희의학 v.17 no.2 소청룡탕이 알레르기 천식 모델 흰쥐의 BALF내 면역세포에 미치는 영향 이준우;정희재;정승기;이형구
  9. 한의학회지 v.23 no.1 맥문동탕과 정천화담강기탕이 알레르기 천식모델 흰쥐의 BALF내 면역세포 및 혈청IgE에 미치는 영향 김진주;정희재;정승기;이형구
  10. 第5回 韓·中 學術大會發表 論文集 麥門冬湯이 알레르기 喘息의 呼吸樣相과 氣管組織에 미치는 影響 유욱상;정희재;정승기;이형구
  11. 慶熙醫學 v.15 no.1 小靑龍湯이 알레르기 喘息의 呼吸樣相과 氣管組織에 미치는 影響 조영민;정희재;정승기;이형구
  12. 경희한의대논문집 v.23 no.1 小靑龍湯이 Asthma model 內의 Cytokine에 미치는 影響 차은수;정희재;정승기;이형구
  13. 대한한의학회지 v.21 no.3 解表二陳湯加減方이 Asthma model 內의 Cytokine에 미치는 影響 백동진;정희재;이형구;정승기
  14. 대한한방내과학회지 v.22 no.3 육미지황탕합사백산과 상백피가 인간 기관지상피세포의 IL-6, IL-8, GM-CSF mRNA level에 미치는 영향 주창엽;황우석;허태석;정희재;정승기;이형구
  15. 사람 Mast cell에서의 케모카인에 대한 白蓮治哮湯의 效果 이형철
  16. 대한한방내과학회지 v.21 no.4 한방치료에 따른 천식환자의 삶의 질에 대한 임상적 평가 한동하;주창엽;허태석;정희재;정승기;이형구
  17. 대한한의학회지 v.22 no.4 소청룡탕이 기관지천식 환자의 폐기능과 삶의 질에 미치는 영향 허태석;황우석;주창엽;정희재;이형구;정승기
  18. 대한한방내과학회지 v.23 no.1 小靑龍湯치료 기관지천식환자의 혈액내 호산구수와 혈청IgE 및 T림프구아형의 변화 황우석;정희재;주창엽;이재성;이경기;이형구등
  19. 대한한의학회지 v.23 no.2 小靑龍湯이 기관지천식 환자의 혈청 IL-4, IL-5, IFN-$\gamma$<\TEX> 변화에 미치는 영향 정승기;허태석;황우석;주창엽;김영우;정희재
  20. Thorax v.36 no.2 Relationship between asthma and gastro-oesophageal reflux Goodall, R.J.;Earis, J.E.;Cooper, D.N.;Bernstein A;Temple, J.G.
  21. Chest. v.111 no.1 Autonomic regulation in asthmatics with gastroesophageal reflux Lodi U;Harding. S.M.;Coghlan, H.C.;Guzzo, M.R.;Walker, L.H.
  22. Allergy v.55 no.Suppl. 61 Gastroesophageal reflux disease and asthma: an intriguing dilemma Astarita C;Gargano D;Cutajar M;Napolitano A;Manguso F;Abbate GF
  23. Med Sci Monit. v.8 no.3 Asthma and gastroesophageal reflux in children Wasowska-Krolikowska K;Toporowska-Kowalska E;Krogulska A
  24. J Asthma v.39 no.2 The pattern of gastroesophageal reflux in asthmatic children Cinquetti M;Micelli S;Voltolina C;Zoppi G
  25. Am J Gastroenterol. v.96 no.5 Respiratory symptoms and pulmonary functional changes in patients with irritable bowel syndrome Yazar A;Atis S;Konca K;Pata C;Akbay E;Calikoglu M;Hafta A
  26. Pharmacoepidemiol Drug Saf. v.11 no.1 Risk of irritable bowel syndrome among asthma patients Huerta C;Garcia Rodriguez LA;Wallander, M.A.;Johansson S
  27. Dig Dis Sci. v.33 no.2 GSRS--a clinical rating scale for gastrointestinal symptoms in patients with irritable bowel syndrome and peptic ulcer disease Svedlund J;Sjodin I;Dotevall G
  28. Acta Psychiatr Scand. v.84 no.1 A comparison of the mental status, personality profiles and life events of patients with irritable bowel syndrome and peptic ulcer disease Dinan, T.G.;O'Keane V;O'Boyle C;Chua A;Keeling, P.W.
  29. Scand J Gastroenterol. v.28 no.8 Quality of life in patients with upper gastrointestinal symptoms. An improved evaluation of treatment regimens? Dimenas E;Glise H;Hallerback B;Hernqvist H;Svedlund J;Wiklund I
  30. Surg Endosc. v.9 no.2 Quality-of-life assessments in evaluation of laparoscopic Rosetti fundoplication Glise H;Hallerback B;Johansson B